4.5 Review

Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, General & Internal

Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients

Samuel W. D. Merriel et al.

Summary: The evidence currently available suggests that PSA is highly sensitive but poorly specific for detecting prostate cancer in symptomatic patients. However, limitations in study design and reference test reduce the certainty of this estimate. There is limited evidence regarding the performance of PSA in primary care, where most testing is done.

BMC MEDICINE (2022)

Review Oncology

Age-Adjusted Reference Values for Prostate Specific Antigen-A Systematic Review and Meta-Analysis

Bashar Matti et al.

Summary: This study systematically evaluates the evidence on ethnic differences in age-adjusted reference values of prostate-specific antigen (PSA). The findings suggest that there are significant ethnic differences in PSA reference values and that these values increase with age.

CLINICAL GENITOURINARY CANCER (2022)

Review Urology & Nephrology

Assessment of prostate-specific antigen screening: an evidence-based report by the German Institute for Quality and Efficiency in Health Care

Ulrike Paschen et al.

Summary: PSA screening reduces the risk of prostate cancer mortality and metastasis, but leads to overdiagnoses and false-positive results, with associated harms such as unnecessary treatments and potential complications from biopsies.

BJU INTERNATIONAL (2022)

Article Oncology

Differences in cancer incidence by broad ethnic group in England, 2013-2017

Christine Delon et al.

Summary: People of non-White minority ethnicity in England generally have lower cancer risk than the White population, though there are a number of notable exceptions.

BRITISH JOURNAL OF CANCER (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Urology & Nephrology

Age-adjusted reference values for prostate-specific antigen in a multi-ethnic population

Bashar Matti et al.

Summary: This study established age-adjusted reference values for prostate-specific antigen in an ethnically diverse population in New Zealand. The results showed that prostate-specific antigen levels increased with age, with significant ethnic differences observed in older age groups.

INTERNATIONAL JOURNAL OF UROLOGY (2021)

Article Public, Environmental & Occupational Health

Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017

David A. Siegel et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Review Medicine, General & Internal

Prostate-Specific Antigen-Based Screening for Prostate Cancer Evidence Report and Systematic Review for the US Preventive Services Task Force

Joshua J. Fenton et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Article Medicine, General & Internal

Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality The CAP Randomized Clinical Trial

Richard M. Martin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Review Medicine, General & Internal

Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis

Dragan Ilic et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Editorial Material Medicine, General & Internal

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

Kari A. O. Tikkinen et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Editorial Material Primary Health Care

Lower urinary tract symptoms and prostate cancer: is PSA testing in men with symptoms wise?

Jasmine Just et al.

BRITISH JOURNAL OF GENERAL PRACTICE (2018)

Editorial Material Psychology, Clinical

Understanding Associations Among Race, Socioeconomic Status, and Health: Patterns and Prospects

David R. Williams et al.

HEALTH PSYCHOLOGY (2016)

Article Medical Laboratory Technology

Total, free, and complexed prostate-specific antigen levels among US men, 2007-2010

David A. Lacher et al.

CLINICA CHIMICA ACTA (2015)

Article Urology & Nephrology

Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone

E. David Crawford et al.

BJU INTERNATIONAL (2011)

Article Oncology

Ethnic differences in prostate cancer

P. Kheirandish et al.

BRITISH JOURNAL OF CANCER (2011)